subscribeSubscribe
Enforcement Report - Week of April 12, 2023

Enforcement Report - Week of April 12, 2023
FDA
12 Apr 2023
Share Share
Enforcement Report - Week of March 8, 2023

Enforcement Report - Week of March 8, 2023
FDA
08 Mar 2023
Share Share
Method`s Generic Doxazosin Mesylate Receives Approval in the U.S.

Method`s Generic Doxazosin Mesylate Receives Approval in the U.S.
FDA
15 Mar 2022
Share Share
This Drug Is Safe and Effective. Wait. Compared With What?

This Drug Is Safe and Effective. Wait. Compared With What?
Aaron E. Carroll NYTIMES
20 Aug 2018
Share Share
Appco Pharma’s Generic Doxazosin Mesylate Receives Approval In US

Appco Pharma’s Generic Doxazosin Mesylate Receives Approval In US
FDA
20 Apr 2018
Share Share
Heritage Pharma’s Generic Doxazosin Mesylate Receives Approval In US

Heritage Pharma’s Generic Doxazosin Mesylate Receives Approval In US
FDA
16 Feb 2018
Share Share
Zydus Cadila gets USFDA nod to market Doxazosin tablets

Zydus Cadila gets USFDA nod to market Doxazosin tablets
ECONOMIC TIMES
18 Oct 2017
Share Share
Zydus Pharm’s Generic Doxazosin Mesylate Receives Tentative Approval In US

Zydus Pharm’s Generic Doxazosin Mesylate Receives Tentative Approval In US
FDA
10 Jul 2017
Share Share
Will Gilead Follow The Pfizer Game Plan For Sales Growth?

Will Gilead Follow The Pfizer Game Plan For Sales Growth?
John LaMattina FORBES
03 Feb 2016
Share Share
Spironolactone `a clear winner` for resistant hypertension

Spironolactone `a clear winner` for resistant hypertension
European Society Of Cardiology (ESC) SCIENCE DAILY
01 Sep 2015
Share Share